Literature DB >> 1311177

Analysis of human hepatic microsomal glucose-6-phosphatase in clinical conditions where the T2 pyrophosphate/phosphate transport protein is absent.

R C Nordlie1, H M Scott, I D Waddell, R Hume, A Burchell.   

Abstract

The availability of a rare set of human hepatic microsomes in which T2, a pyrophosphate/phosphate transport protein of the glucose-6-phosphatase system, has been shown immunologically to be completely absent, has permitted further characterization of multicomponent glucose-6-phosphatase (EC 3.1.3.9). Pyrophosphatase activity in intact microsomes was found to be totally absent, but was normal in disrupted microsomes. However, Pi did not accumulate within the lumen of the microsomes when glucose 6-phosphate was the substrate. This was not as predicted if there is only one transport protein in the endoplasmic reticulum capable of transporting Pi, produced by glucose-6-phosphatase, out of the lumen. The results suggest that the pyrophosphate/phosphate transport system of human hepatic endoplasmic reticulum must be more complex than previously thought, as it must comprise at least two protein components.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1311177      PMCID: PMC1130768          DOI: 10.1042/bj2810859

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  29 in total

Review 1.  The molecular basis of the hepatic microsomal glucose-6-phosphatase system.

Authors:  A Burchell; I D Waddell
Journal:  Biochim Biophys Acta       Date:  1991-04-17

2.  Stabilization of glucose-6-phosphatase activity by a 21 000-dalton hepatic microsomal protein.

Authors:  A Burchell; B Burchell; M Monaco; H E Walls; W J Arion
Journal:  Biochem J       Date:  1985-09-01       Impact factor: 3.857

3.  The inhibition by physiological orthophosphate concentrations of hydrolytic and synthetic activities of liver glucose 6-phosphatase.

Authors:  A L Vianna; R C Nordlie
Journal:  J Biol Chem       Date:  1969-08-10       Impact factor: 5.157

4.  A new microtechnique for the analysis of the human hepatic microsomal glucose-6-phosphatase system.

Authors:  A Burchell; R Hume; B Burchell
Journal:  Clin Chim Acta       Date:  1988-04-15       Impact factor: 3.786

5.  UDP-glucuronyltransferase in perfused rat liver and in microsomes - III. Effects of galactosamine and carbon tetrachloride on the glucuronidation of 1-naphthol and bilirubin.

Authors:  G Otani; M M Abou-El-Makarem; K W Bock
Journal:  Biochem Pharmacol       Date:  1976-06-01       Impact factor: 5.858

6.  The ontogeny of human hepatic microsomal glucose-6-phosphatase proteins.

Authors:  A Burchell; L Gibb; I D Waddell; M Giles; R Hume
Journal:  Clin Chem       Date:  1990-09       Impact factor: 8.327

7.  Hepatic microsomal glucose-6-phosphatase system and sudden infant death syndrome.

Authors:  A Burchell; J E Bell; A Busuttil; R Hume
Journal:  Lancet       Date:  1989-08-05       Impact factor: 79.321

8.  Quantitation of rabbit cytochrome P-450, form 2, in microsomal preparations bound directly to nitrocellulose paper using a modified peroxidase-immunostaining procedure.

Authors:  B A Domin; C J Serabjit-Singh; R M Philpot
Journal:  Anal Biochem       Date:  1984-02       Impact factor: 3.365

9.  The phosphohydrolase component of the hepatic microsomal glucose-6-phosphatase system is a 36.5-kilodalton polypeptide.

Authors:  J L Countaway; I D Waddell; A Burchell; W J Arion
Journal:  J Biol Chem       Date:  1988-02-25       Impact factor: 5.157

10.  Type Ic, a novel glycogenosis. Underlying mechanism.

Authors:  R C Nordlie; K A Sukalski; J M Muñoz; J J Baldwin
Journal:  J Biol Chem       Date:  1983-08-25       Impact factor: 5.157

View more
  11 in total

1.  NPT4, a new microsomal phosphate transporter: mutation analysis in glycogen storage disease type Ic.

Authors:  D Melis; A C Havelaar; E Verbeek; G P A Smit; A Benedetti; G M S Mancini; F Verheijen
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

Review 2.  A retrospective review of the roles of multifunctional glucose-6-phosphatase in blood glucose homeostasis: Genesis of the tuning/retuning hypothesis.

Authors:  Robert C Nordlie; James D Foster
Journal:  Life Sci       Date:  2010-07-21       Impact factor: 5.037

3.  Evidence for high-capacity bidirectional glucose transport across the endoplasmic reticulum membrane by genetically encoded fluorescence resonance energy transfer nanosensors.

Authors:  Marcus Fehr; Hitomi Takanaga; David W Ehrhardt; Wolf B Frommer
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

Review 4.  The glucose-6-phosphatase system.

Authors:  Emile van Schaftingen; Isabelle Gerin
Journal:  Biochem J       Date:  2002-03-15       Impact factor: 3.857

5.  Changes in the glucose-6-phosphatase complex in hepatomas.

Authors:  Q Xiao; I Jaspers; E Matthew; M A Lea
Journal:  Mol Cell Biochem       Date:  1993-05-12       Impact factor: 3.396

6.  The hepatic glucose-6-phosphatase system in Ehrlich-ascites-tumour-bearing mice.

Authors:  R W Lucius; I D Waddell; A Burchell; R C Nordlie
Journal:  Biochem J       Date:  1993-03-15       Impact factor: 3.857

7.  Multiple transport protein defects in a patient with glycogen storage disease type 1: GSD 1b/1c beta.

Authors:  R A Hawkins; K R Kamath; H M Scott; A Burchell
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

8.  The human embryonic-fetal kidney endoplasmic reticulum phosphate-pyrophosphate transport protein.

Authors:  R Hume; H Brewerton; A Burchell
Journal:  Virchows Arch       Date:  1996-03       Impact factor: 4.064

9.  Fatty acyl-CoA esters inhibit glucose-6-phosphatase in rat liver microsomes.

Authors:  R Fulceri; A Gamberucci; H M Scott; R Giunti; A Burchell; A Benedetti
Journal:  Biochem J       Date:  1995-04-15       Impact factor: 3.857

10.  Permeability of rat liver microsomal membrane to glucose 6-phosphate.

Authors:  R Fulceri; G Bellomo; A Gamberucci; H M Scott; A Burchell; A Benedetti
Journal:  Biochem J       Date:  1992-09-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.